U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 191

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:196711023
GRCh38:
Chr1:196741893
CFHL992*Hemolytic uremic syndrome, atypical, susceptibility to, 1Likely pathogenic
(Jun 13, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr1:196712754
GRCh38:
Chr1:196743624
CFHC1102WBasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Mar 30, 2021)
criteria provided, single submitter
3.
GRCh37:
Chr1:196712621-196712630
GRCh38:
Chr1:196743491-196743500
CFHFactor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1Likely pathogenic
(Jan 20, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr1:196712608
GRCh38:
Chr1:196743478
CFHV1054Inot provided, Basal laminar drusen, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency
Uncertain significance
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr1:196715085
GRCh38:
Chr1:196745955
CFHI1150RHemolytic uremic syndrome, atypical, susceptibility to, 1Uncertain significance
(May 22, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr1:196788993
GRCh38:
Chr1:196819863
CFHR1Age related macular degeneration 1, Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Conflicting interpretations of pathogenicity
(Dec 1, 2022)
criteria provided, conflicting interpretations
7.
GRCh37:
Chr1:196709736-196709737
GRCh38:
Chr1:196740606-196740607
CFHFactor H deficiency, Basal laminar drusen, not provided,
Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Atypical hemolytic-uremic syndrome
Benign/Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr1:196642092
GRCh38:
Chr1:196672962
CFHBasal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, not provided, Factor H deficiency,
Basal laminar drusen, Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr1:196696088
GRCh38:
Chr1:196726958
CFHBasal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, Basal laminar drusen, Factor H deficiency,
not provided, Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr1:196710990
GRCh38:
Chr1:196741860
CFHBasal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, Basal laminar drusen, Factor H deficiency,
not provided, Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr1:196654309
GRCh38:
Chr1:196685179
CFHAge related macular degeneration 4, Basal laminar drusen, Factor H deficiency,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Likely benign
(Oct 7, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr1:196643107
GRCh38:
Chr1:196673977
CFHnot provided, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, Age related macular degeneration 4, Basal laminar drusen,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency, Age related macular degeneration 4
Benign/Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr1:196695798
GRCh38:
Chr1:196726668
CFHnot provided, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, Age related macular degeneration 4, Basal laminar drusen,
Age related macular degeneration 4, Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr1:196709787
GRCh38:
Chr1:196740657
CFHV941FBasal laminar drusen, Age related macular degeneration 4, Factor H deficiency,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Benign/Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr1:196642970
GRCh38:
Chr1:196673840
CFHBasal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, Basal laminar drusen, Factor H deficiency,
Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Benign/Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr1:196711093
GRCh38:
Chr1:196741963
CFHKidney disorder, Basal laminar drusen, Factor H deficiency,
Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Conflicting interpretations of pathogenicity
(Jul 12, 2022)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr1:196654210
GRCh38:
Chr1:196685080
CFHBasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Likely benign
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr1:196709912
GRCh38:
Chr1:196740782
CFHnot provided, Basal laminar drusen, Age related macular degeneration 4,
Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Atypical hemolytic-uremic syndrome
Benign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr1:196642969-196642970
GRCh38:
Chr1:196673839-196673840
CFHHemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency, Basal laminar drusen,
Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Basal laminar drusen, not provided, Age related macular degeneration 4
Benign/Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr1:196643060
GRCh38:
Chr1:196673930
CFHBasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Likely benign
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr1:196709834
GRCh38:
Chr1:196740704
CFHnot provided, Basal laminar drusen, Factor H deficiency,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Age related macular degeneration 4
Likely benign
(Mar 19, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr1:196695724
GRCh38:
Chr1:196726594
CFHK666Nnot provided, Age related macular degeneration 4, Factor H deficiency,
Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Jul 1, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr1:196683039
GRCh38:
Chr1:196713909
CFHT504Mnot provided, Inborn genetic diseases, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, Age related macular degeneration 4, Basal laminar drusen
Uncertain significance
(Mar 2, 2023)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr1:196695780
GRCh38:
Chr1:196726650
CFHI685Tnot provided, Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Age related macular degeneration 4, Basal laminar drusen
Uncertain significance
(Dec 17, 2021)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr1:196694427
GRCh38:
Chr1:196725297
CFHE625*not provided, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, Age related macular degeneration 4
Pathogenic
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr1:196695773
GRCh38:
Chr1:196726643
CFHV683MBasal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, CFH-related condition, not provided
Uncertain significance
(Feb 16, 2023)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr1:196706028
GRCh38:
Chr1:196736898
CFHR830WHemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency, Basal laminar drusen,
Age related macular degeneration 4, not provided
Uncertain significance
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr1:196714994
GRCh38:
Chr1:196745864
CFHI1120Fnot provided, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, Basal laminar drusen
Uncertain significance
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr1:196642262
GRCh38:
Chr1:196673132
CFHW71*Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, CFH-related condition, not provided
Pathogenic/Likely pathogenic
(Mar 28, 2023)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr1:196711178
GRCh38:
Chr1:196742048
CFHR1044Gnot provided, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, Basal laminar drusen
Uncertain significance
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr1:196694248
GRCh38:
Chr1:196725118
CFHHemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency, Basal laminar drusen,
Basal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided, Age related macular degeneration 4
Uncertain significance
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr1:196646654
GRCh38:
Chr1:196677524
CFHS159NBasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Uncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr1:196643074
GRCh38:
Chr1:196673944
CFHV111EBasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Uncertain significance
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr1:196695648
GRCh38:
Chr1:196726518
CFHV641ABasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Uncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr1:196654292
GRCh38:
Chr1:196685162
CFHG297SBasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr1:196696029
GRCh38:
Chr1:196726899
CFHT732MFactor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen,
Age related macular degeneration 4, not provided
Uncertain significance
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr1:196705956
GRCh38:
Chr1:196736826
CFHA806SFactor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen,
Age related macular degeneration 4, not provided
Uncertain significance
(May 13, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr1:196683002
GRCh38:
Chr1:196713872
CFHI492VFactor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen,
Age related macular degeneration 4, not provided
Uncertain significance
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr1:196705996
GRCh38:
Chr1:196736866
CFHN819SBasal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, not provided
Uncertain significance
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr1:196646675
GRCh38:
Chr1:196677545
CFHR166LAge related macular degeneration 4, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, not provided
Uncertain significance
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr1:196646704
GRCh38:
Chr1:196677574
CFHF176LAge related macular degeneration 4, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, not provided
Uncertain significance
(Dec 30, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr1:196642149
GRCh38:
Chr1:196673019
CFHT34Snot provided, Age related macular degeneration 4, Basal laminar drusen,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency
Uncertain significance
(May 19, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr1:196646743
GRCh38:
Chr1:196677613
CFHE189KAge related macular degeneration 4, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, not provided
Uncertain significance
(Apr 6, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr1:196694298
GRCh38:
Chr1:196725168
CFHR582Cnot provided, Age related macular degeneration 4, Basal laminar drusen,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency
Uncertain significance
(Dec 26, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr1:196716363
GRCh38:
Chr1:196747233
CFHR1206CHemolytic uremic syndrome, atypical, susceptibility to, 1Likely pathogenic
(Feb 23, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr1:196648805
GRCh38:
Chr1:196679675
CFHK224NHemolytic uremic syndrome, atypical, susceptibility to, 1Uncertain significance
(Jan 3, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr1:196695906
GRCh38:
Chr1:196726776
CFHC691SAge related macular degeneration 4, Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Basal laminar drusen, not provided
Uncertain significance
(Oct 29, 2021)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr1:196712598
GRCh38:
Chr1:196743468
CFHKidney disorder, Age related macular degeneration 4, Factor H deficiency,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen, not specified
Benign/Likely benign
(Dec 30, 2021)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr1:196658763
GRCh38:
Chr1:196689633
CFHAge related macular degeneration 4, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided,
Age related macular degeneration 4, Factor H deficiency, Basal laminar drusen
Benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr1:196682885
GRCh38:
Chr1:196713755
CFHI453LAge related macular degeneration 4, Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Basal laminar drusen, Atypical hemolytic-uremic syndrome with I factor anomaly
Uncertain significance
(Nov 4, 2021)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr1:196642072
GRCh38:
Chr1:196672942
CFHAge related macular degeneration 4, not provided, Basal laminar drusen,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency
Benign
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr1:196642969-196642970
GRCh38:
Chr1:196673839-196673840
CFHAtypical hemolytic-uremic syndrome, Factor H deficiency, Age related macular degeneration 4,
not provided, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Benign/Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr1:196642969-196642970
GRCh38:
Chr1:196673839-196673840
CFHAtypical hemolytic-uremic syndrome, Factor H deficiency, not provided,
Age related macular degeneration 4, not specified, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Age related macular degeneration 4, Factor H deficiency, Basal laminar drusen,
Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1 ...see more
Benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr1:196762488-196762489
GRCh38:
Chr1:196793358-196793359
CFHR3I219fs, I280fsnot specified, not provided, Age related macular degeneration 1,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Jul 21, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr1:196642171
GRCh38:
Chr1:196673041
CFHT41IHemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency, Age related macular degeneration 4,
Basal laminar drusen, not provided
Uncertain significance
(Jan 1, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr1:196642970
GRCh38:
Chr1:196673840
CFHAge related macular degeneration 4, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, not provided, Age related macular degeneration 4,
Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency
Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr1:196654252
GRCh38:
Chr1:196685122
CFHnot provided, Basal laminar drusen, Factor H deficiency,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Age related macular degeneration 4
Likely benign
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr1:196654385
GRCh38:
Chr1:196685255
CFHnot provided, Age related macular degeneration 4, Basal laminar drusen,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency, Age related macular degeneration 4,
Factor H deficiency, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Likely benign
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr1:196695661
GRCh38:
Chr1:196726531
CFHnot provided, Basal laminar drusen, Age related macular degeneration 4,
Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr1:196642206
GRCh38:
Chr1:196673076
CFHR53Cnot provided, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency, Age related macular degeneration 4
Pathogenic/Likely pathogenic
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr1:196711127
GRCh38:
Chr1:196741997
CFHA1027PBasal laminar drusen, Factor H deficiency, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Uncertain significance
(Sep 9, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr1:196646684
GRCh38:
Chr1:196677554
CFHH169RHemolytic uremic syndrome, atypical, susceptibility to, 1, CFH-related disorder, not provided
Uncertain significance
(Nov 10, 2023)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr1:196646675
GRCh38:
Chr1:196677545
CFHR166Qnot provided, Basal laminar drusen, Basal laminar drusen,
Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Age related macular degeneration 4
Uncertain significance
(Sep 3, 2021)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr1:196799665
GRCh38:
Chr1:196830535
CFHR1D160N, D198N, D134N, D150N, D159N, D215N, D147N, D161NHemolytic uremic syndrome, atypical, susceptibility to, 1Uncertain significance
(Jul 8, 2020)
criteria provided, single submitter
65.
GRCh37:
Chr1:196695985
GRCh38:
Chr1:196726855
CFHF717LHemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen, Age related macular degeneration 4,
Factor H deficiency, not provided
Uncertain significance
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr1:196648780
GRCh38:
Chr1:196679650
CFHI216TInborn genetic diseases, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Age related macular degeneration 4, Basal laminar drusen, not provided
Uncertain significance
(Aug 25, 2023)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr1:196646650
GRCh38:
Chr1:196677520
CFHV158Inot provided, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen,
Factor H deficiency, Age related macular degeneration 4
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr1:196659231
GRCh38:
Chr1:196690101
CFHQ400KHemolytic uremic syndrome, atypical, susceptibility to, 1, Basal laminar drusen, Factor H deficiency,
Age related macular degeneration 4, Factor H deficiency, not provided
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr1:196694379
GRCh38:
Chr1:196725249
CFHV609IAge related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1, Factor H deficiency,
Basal laminar drusen, not provided
Uncertain significance
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr1:196684819
GRCh38:
Chr1:196715689
CFHG539VHemolytic uremic syndrome, atypical, susceptibility to, 1Uncertain significanceno assertion criteria provided
71.
GRCh37:
Chr1:196621280
GRCh38:
Chr1:196652150
CFHM11IBasal laminar drusen, not provided, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
Uncertain significance
(Aug 17, 2021)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr1:196706144
GRCh38:
Chr1:196737014
CFHnot provided, Basal laminar drusen, Age related macular degeneration 4,
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Sep 24, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr1:196682979
GRCh38:
Chr1:196713849
CFHA484VBasal laminar drusen, Age related macular degeneration 4, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
74.
GRCh37:
Chr1:196654310
GRCh38:
Chr1:196685180
CFHR303WBasal laminar drusen, not provided, Age related macular degeneration 4,
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
75.
GRCh37:
Chr1:196621263
GRCh38:
Chr1:196652133
CFHK6EBasal laminar drusen, not provided, Age related macular degeneration 4,
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr1:196621254
GRCh38:
Chr1:196652124
CFHL3VBasal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Uncertain significance
(Sep 30, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr1:196712604
GRCh38:
Chr1:196743474
CFHAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr1:196712577
GRCh38:
Chr1:196743447
CFHAtypical hemolytic-uremic syndrome, Age related macular degeneration 4, Basal laminar drusen,
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Feb 1, 2020)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr1:196706771
GRCh38:
Chr1:196737641
CFHBasal laminar drusen, Age related macular degeneration 4, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr1:196705964
GRCh38:
Chr1:196736834
CFHI808MBasal laminar drusen, Age related macular degeneration 4, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
not provided, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Sep 17, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr1:196695710
GRCh38:
Chr1:196726580
CFHR662GAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr1:196682946
GRCh38:
Chr1:196713816
CFHA473Vnot provided, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Basal laminar drusen,
Age related macular degeneration 4, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Oct 8, 2022)
criteria provided, conflicting interpretations
83.
GRCh37:
Chr1:196654282
GRCh38:
Chr1:196685152
CFHAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr1:196642972
GRCh38:
Chr1:196673842
CFHHemolytic uremic syndrome, atypical, susceptibility to, 1, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, not provided,
Basal laminar drusen, Age related macular degeneration 4
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr1:196712739
GRCh38:
Chr1:196743609
CFHBasal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Age related macular degeneration 4
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
86.
GRCh37:
Chr1:196709935
GRCh38:
Chr1:196740805
CFHAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Conflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr1:196709910
GRCh38:
Chr1:196740780
CFHP982SAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Apr 27, 2017)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr1:196697553
GRCh38:
Chr1:196728423
CFHD772NAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Mar 2, 2018)
criteria provided, single submitter
89.
GRCh37:
Chr1:196697517
GRCh38:
Chr1:196728387
CFHI760LAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, Inborn genetic diseases
Uncertain significance
(Nov 30, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr1:196642221
GRCh38:
Chr1:196673091
CFHS58ACFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Basal laminar drusen, Age related macular degeneration 4,
Hemolytic uremic syndrome, atypical, susceptibility to, 1, not provided
Conflicting interpretations of pathogenicity
(Sep 26, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr1:196716570
GRCh38:
Chr1:196747440
CFHAge related macular degeneration 4, Basal laminar drusen, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,
Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr1:196684815
GRCh38:
Chr1:196715685
CFHD538Hnot provided, Basal laminar drusen, Age related macular degeneration 4,
Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1
Uncertain significance
(Sep 5, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr1:196694253
GRCh38:
Chr1:196725123
CFHR567GBasal laminar drusen, Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Age related macular degeneration 4
Uncertain significance
(Oct 1, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr1:196709760
GRCh38:
Chr1:196740630
CFHK932QHemolytic uremic syndrome, atypical, susceptibility to, 1Uncertain significance
(Apr 26, 2019)
no assertion criteria provided
95.
GRCh37:
Chr1:196706073-196706074
GRCh38:
Chr1:196736943-196736944
CFHQ846fsHemolytic uremic syndrome, atypical, susceptibility to, 1Pathogenic
(Apr 26, 2019)
no assertion criteria provided
96.
GRCh37:
Chr1:196709866
GRCh38:
Chr1:196740736
CFHG967Enot providedUncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr1:196712580
GRCh38:
Chr1:196743450
CFHHemolytic uremic syndrome, atypical, susceptibility to, 1Pathogenic
(Apr 4, 2019)
no assertion criteria provided
98.
GRCh37:
Chr17:54926110
GRCh38:
Chr17:56848749
DGKEN314KHemolytic uremic syndrome, atypical, susceptibility to, 1Likely pathogenic
(Nov 14, 2019)
criteria provided, single submitter
99.
GRCh37:
Chr17:54912601
GRCh38:
Chr17:56835240
DGKEK150fsHemolytic uremic syndrome, atypical, susceptibility to, 1Pathogeniccriteria provided, single submitter
100.
GRCh37:
Chr1:196714954
GRCh38:
Chr1:196745824
CFHAge related macular degeneration 4, Basal laminar drusen, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Factor H deficiency, not provided
Likely benign
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination